Newormics is an Austin-based biotechnology company, offering in vivo toxicology testing services using C. elegans. Newormics is the exclusive licensee of a microfluidics-based technology, vivoChip®, that allows high-throughput and high-content analysis of C. elegans. This platform has been sold to C. elegans researchers around the globe for accelerating their image-based studies. At Newormics, we are fully committed to making significant social and economic contributions by helping to bring safer chemicals and drugs to the market with reduced development cost, time, and the number of higher-order vertebrate animal testing.
Currently available positions